dendrogenin B (Affichem)

N/A

Report date: 2025/01/26 18:53:44
NME

Base Information

Drug Namedendrogenin B (Affichem)
Drug Alias Namedendrogenin BAF-243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsRetinal DiseasesSpinal Cord InjuriesAlzheimer Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffichem
China Registration ClassN/A

Develop Information

Active CompaniesAffichem
Inactive CompaniesN/A
Active IndicationsHearing Loss, Noise-InducedDeafness
Inactive IndicationsRetinal DiseasesSpinal Cord InjuriesAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A